Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erlichman

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|October 1, 1995
Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesisJ Pressacco, J S Wiley, G P Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Comparison of potential markers of farnesyltransferase inhibitionA A Adjei, J N Davis, C Erlichman, et al.
Social Science & Medicine (1982)|January 1, 1991
Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participationH A Llewellyn-Thomas, M J McGreal, E C Thiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell linesA A Adjei, J N Davis, L M Bruzek, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1996
A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinomaV Hsue, C S Wong, M Moore, et al.
Clinical Pharmacology and Therapeutics|December 1, 1988
Rapid development of enhanced clearance after high-dose cyclophosphamideM J Moore, R W Hardy, J J Thiessen, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Limited sampling models for CPT-11, SN-38, and SN-38 glucuronideJ A Sloan, P Atherton, J Reid, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancerM J Moore, L Kaizer, C Erlichman, et al.
Cancer Treatment Reports|August 1, 1980
Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activityT W Kensler, C Erlichman, H N Jayaram, et al.
Cancer Treatment Reports|February 1, 1985
Phase II trial of diaziquone in patients with colon cancerJ A Neidhart, C Erlichman, F Robert, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|October 1, 1995
Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesisJ Pressacco, J S Wiley, G P Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Comparison of potential markers of farnesyltransferase inhibitionA A Adjei, J N Davis, C Erlichman, et al.
Social Science & Medicine (1982)|January 1, 1991
Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participationH A Llewellyn-Thomas, M J McGreal, E C Thiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell linesA A Adjei, J N Davis, L M Bruzek, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1996
A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinomaV Hsue, C S Wong, M Moore, et al.
Clinical Pharmacology and Therapeutics|December 1, 1988
Rapid development of enhanced clearance after high-dose cyclophosphamideM J Moore, R W Hardy, J J Thiessen, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Limited sampling models for CPT-11, SN-38, and SN-38 glucuronideJ A Sloan, P Atherton, J Reid, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancerM J Moore, L Kaizer, C Erlichman, et al.
Cancer Treatment Reports|August 1, 1980
Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activityT W Kensler, C Erlichman, H N Jayaram, et al.
Cancer Treatment Reports|February 1, 1985
Phase II trial of diaziquone in patients with colon cancerJ A Neidhart, C Erlichman, F Robert, et al.
Pageof 10